Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why Ocwen Financial, Deutsche Bank, and Three Other Stocks Are Trending Today

It’s been a relatively quiet day on Wall Street so far as the S&P 500 has opened in the green and has stayed flat in morning trading. Some traders are unwilling to make any moves until the outcome of tomorrow’s Brexit vote is certain.

In this article, we take a look at the reasons why five stocks, Ocwen Financial Corp (NYSE:OCN), Paratek Pharmaceuticals Inc (NASDAQ:PRTK), Carolina Bank Holding Inc. (NC) (NASDAQ:CLBH), First Bancorp (NASDAQ:FBNC), and Deutsche Bank AG (USA) (NYSE:DB), are in the spotlight and see how hedge funds and other investors we track are positioned towards them.

While there are many metrics that investors can assess in the investment process, the hedge fund sentiment is something that is often overlooked. However, hedge funds and other institutional investors allocate significant resources while making their bets and their long-term focus makes them the perfect investors to emulate. This is supported by our research, which determined that following the small-cap stocks that hedge funds are collectively bullish on can help a smaller investor to beat the S&P 500 by around 95 basis points per month (see the details here).

pocket, paper currency, biz, stock exchange, money to burn, success, paying, exchange rate, chocolate gelt, abundance, flowing, coin, european union currency, home finances, currency


Ocwen Rises on Fitch Affirmation

Ocwen Financial Corp (NYSE:OCN) shares are more than 2% higher after credit ratings agency Fitch affirmed Ocwen’s long-term issuer default ratings as ‘B-‘. The ratings agency also affirmed Ocwen’s senior unsecured notes at ‘CC/RR6’ and said its ratings outlook is stable. Ocwen is expected to cut $300 million in operational costs this year and has $280.5 million in unrestricted cash as of March 31, 2016. Shares of Ocwen are nevertheless down 76% year-to-date as the company struggles to remain profitable. A total of 19 funds from our database had a long position in Ocwen Financial Corp (NYSE:OCN) at the end of March.

Follow Ocwen Financial Corp (NYSE:OCN)
Trade (NYSE:OCN) Now!

Paratek Down on Offering

Paratek Pharmaceuticals Inc (NASDAQ:PRTK) shares are 1.5% in the red this morning after the company priced its previously announced public offering of 4.25 million shares of common stock at $13 per share before underwriting discounts and commissions. Paratek has also granted underwriters the 30-day option to buy up to 637,500 additional shares of common stock. Net proceeds from the offering is expected to amount to around $51.4 million. Of the 766 elite funds we track, 10 funds owned $64.8 million worth of Paratek Pharmaceuticals Inc (NASDAQ:PRTK)’s stock, which accounted for 24.40% of the float on March 31, versus 11 funds and $71.01 million, respectively, on December 31.

Follow Paratek Pharmaceuticals Inc. (NASDAQ:PRTK)
Trade (NASDAQ:PRTK) Now!

On the next page, we examine Carolina Bank Holding, First Bancorp, and Deutsche Bank AG.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.